Johnson & Johnson News Headlines

JNJ 
$104.07
*  
1.31
1.27%
Get JNJ Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading JNJ now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    JNJ After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog
9/22/2014 3:45:00 PM - Zacks.com


Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
9/22/2014 2:59:00 PM - Zacks.com


Surprising Silver Lining for Gilead Sciences, inc. Stock
9/22/2014 2:37:02 PM - Motley Fool


Is the Stock Market Ready to Plunge? Here Are 3 Things to Do Right Now
9/22/2014 1:16:02 PM - Motley Fool


Double Your Passive Income With This Dividend Investment Strategy
9/22/2014 10:26:01 AM - VectorVest


The Point Of No (Negative) Return
9/21/2014 7:00:00 AM - Seeking Alpha


3 Ways to Outperform the Market with Quality ETFs - ETF News And Commentary
9/19/2014 1:00:01 PM - Zacks.com


XLV, JNJ, AMGN, BMY: ETF Inflow Alert
9/19/2014 10:00:14 AM - BNK Invest


Why You Should Sell Bristol-Myers Squibb And Buy Johnson & Johnson Instead
9/19/2014 8:43:00 AM - Seeking Alpha


3 Best Stocks to Invest in Pharma
9/19/2014 8:13:02 AM - Motley Fool


Head-To-Head Comparison: Pfizer Vs. Johnson & Johnson On Environmental Metrics
9/18/2014 3:49:00 PM - Seeking Alpha


Retired Investors Should Not Fear Recessions Or A Bad Market: Part 1
9/18/2014 11:13:00 AM - Seeking Alpha


Gilead Sciences, inc. Stock's Incoming Game Changer
9/18/2014 7:45:02 AM - Motley Fool


Don't Own A Company If You Wouldn't Display It On Your Wall
9/17/2014 11:11:00 PM - Seeking Alpha


3 Hot Ways to Play the Biotechnology Bonanza
9/17/2014 9:52:17 AM - InvestorPlace Media


Actavis Is The Best Bet In The Drug Sector
9/17/2014 9:35:00 AM - Seeking Alpha


New Active ETF for All Risk Environments
9/17/2014 9:05:47 AM - Benzinga


Johnson & Johnson: Slow And Steady Core Holding, But No Discount Here
9/17/2014 5:07:00 AM - Seeking Alpha


Buy The Dip In Gilead: Why A Decrease In Quarterly Sovaldi Revenue Is Expected
9/16/2014 12:31:00 PM - Seeking Alpha


Is There Further Upside In Medivation?
9/16/2014 8:27:00 AM - Seeking Alpha


Peregrine Pharmaceuticals Inc. (PPHMP) Ex-Dividend Date Scheduled for September 17, 2014
9/16/2014 8:00:02 AM - NASDAQ.com News


Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious
9/15/2014 8:41:00 AM - Seeking Alpha


New Diabetes Drugs Gain Approval - Florins Versus Oral Insulin
9/14/2014 2:15:00 PM - Seeking Alpha


How to Make Money in Stocks Without Taking Big Risks
9/14/2014 11:02:03 AM - Motley Fool


Retirement Strategy: How Will Rising Interest Rates Affect Dividend Growth Investors?
9/14/2014 6:30:00 AM - Seeking Alpha